MFPL involved in the new interdisciplinary Comammox research platform
MFPL scientist and head of the Department of Structural and Computational Biology Kristina Djinovic-Carugo, together with Michael Wagner (Head of the Research Network Chemistry Meets Microbiology and the Department of Microbiology and Ecosystem Science), Holger Daims (group leader at the Department of Microbiology and Ecosystem Science), and Andreas Richter (Head of the Terrestrial Ecosystems Unit at the Department of Microbiology and Ecosystem Science) received funding of €470.000 from the University of Vienna for their new interdisciplinary research platform focussing on comammox bacteria.
ERC Starting Grant for physicist Thomas Juffmann
Thomas Juffmann is awarded a renowned ERC Starting Grant of the European Research Council, which funds ground-breaking basic research. The funding of €1.5 million enables Juffmann to develop new microscopy methods at the interface of physics and biology. Dr. Juffmann, a member of the University Physics department, will now establish his research group at MFPL to foster interdisciplinarity and innovative collaborations.
Four FWF grants for MFPL scientists
We congratulate our researchers Andreas Bachmair, Thomas Decker, Verena Jantsch and Dea Slade on being awarded four FWF grants for their proposed research projects. The FWF will support their future work with a total of more than €1.5 million over the next three years.
Doc.Award 2018 for Iva Lučić
Congratulations to Iva Lučić on her Doc.Award from the University of Vienna! Iva recently completed her PhD in Thomas Leonard’s lab at the MFPL.
Female power at NaturTalente 2018: Now with focus on Life Sciences
The competence program of UNIPORT, “NaturTalente”, has entered its fourth round in 2018. Designed specifically for excellent students, the initiative aims at establishing a network between students from life sciences, chemistry, and the Medical University of Vienna and influential industry partners.
International FWF grant for MFPL scientist Martin Leeb
We congratulate stem cell researcher Martin Leeb on winning an International FWF grant for the research project “Systems biology of embryonic stem cell differentiation”.
A technology award for the University of Vienna and MFPL
Dr. Nadezda Sedlyarova, researcher of the University of Vienna at the Max F. Perutz Laboratories (MFPL), and Dr. Jürgen Mairhofer of enGenes Biotech GmbH, were awarded one of three prizes from START:IP 2018 for their collaborative evaluation of an innovative technology developed in the laboratory of Prof. Renée Schroeder at the MFPL.
Learning about a human genetic disease from plants
Fanconi anemia is a rare human genetic disease characterized by severe pathologies like predisposition to cancer, congenital defects and infertility. Previous studies have shown that most of the genes affected in the disorder are implicated in DNA repair. As studies on germ cells (the precursor cells of egg and sperm cells) carrying mutations in Fanconi anemia genes have proven to be extremely challenging in animal models, the Schlögelhofer group at MFPL have used the model plant Arabidopsis thaliana to investigate the role of a key protein in Fanconi anemia – Fanconi anemia D2 protein (FANCD2).
Molecule linked to antagonistic mechanisms that keep muscle proteins in shape
Scientists in Vienna discover two distinct roles for the molecule UNC-45 in keeping muscle proteins in the right shape: on its own it steers the assembly of a muscle protein; in conjunction with a partner it triggers the degradation of severely damaged muscle proteins. The findings, reported in Nature Communications, may help to better understand muscular diseases.
Collecting the right waste: insights into the molecular mechanism of p62-mediated autophagy
Waste management is a big problem, and not only for us but also for our cells. In order to remain healthy, our cells must constantly collect and degrade the waste that is produced inside them. If this harmful material accumulates cells will ultimately die, affecting the health of the entire organism. For example, many degenerative diseases such as Alzheimer’s and Parkinson’s diseases are thought to arise from the accumulation of harmful waste inside the cells.
Two ERC Consolidator Grants for the MFPL
MFPL group leaders Claudine Kraft (University of Vienna) and Alwin Köhler (Medical University of Vienna) are each awarded a prestigious ERC Consolidator Grant. One of the most meaningful awards for researchers in Europe, the ERC Consolidator Grant will support their research in recognition of their future potential and past achievements. The funding amounts to EUR 2.000.000 over the course of five years for each grant.
Veni Vidi Vici: How natural killer cells conquer the superbug Klebsiella
Multidrug resistance of microbes poses a serious global threat to human health. Such resistant strains of Klebsiella pneumoniae significantly reduce therapeutic options for the treatment of Klebsiella-induced, potentially fatal pneumonia or sepsis. Pavel Kovarik and his team at the Max F. Perutz Laboratories (MFPL), a joint venture of the University of Vienna and the Medical University of Vienna, together with colleagues at Queen’s University Belfast now report new insights into how immune cells communicate at the site of infection and join forces in the fight against Klebsiella infections. Their results, published in the journal PLOS Pathogens, might be used for the development of alternatives to ineffective anti-microbial drugs.
office@maxperutzlabs.ac.at
+43 1 4277 240 01
Vienna BioCenter Dr.-Bohr-Gasse 9, 1030 Vienna
This website uses cookies to ensure you get the best experience on our website.
» Privacy Policy